Globe Newswire
PRESS RELEASE
- Strategic research collaboration to advance MTx’s recombinant polyclonal IgG technology
- Agreement includes R&D funding for exploratory work, technology access and, assuming exercise of the option by CSL, a license fee, and development and sales milestones of up to CHF 265 million (USD 328 million)
- Provides further validation of MTx's proprietary DROPZYLLA® technology platform
Schlieren / Zurich, Switzerland, 9 February, 2026 – Memo Therapeutics AG... (continue reading...)
ANN ARBOR, Mich., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced its 2026 production plan that will drive explosive growth and establish a new global benchmark for spider silk manufacturing.
Kraig's technology is built upon the use of modified silkworms to produce recombinant spider silk. Within the next 30 days, the Company will... (continue reading...)
Atlanta, GA., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Outdoor Holding Company (Nasdaq: POWW, POWWP) (“OHC,” “we,” “us,” “our” or the “Company”), the owner of GunBroker.com, the largest online marketplace for firearms, hunting and related products, today reported its financial results for its third fiscal quarter ended December 31, 2025.
Third Quarter Fiscal 2026 vs. Third Quarter Fiscal 2025
Financial Highlights
-Net revenues increased 7% to $13.39 million from $12.52... (continue reading...)- Obexelimab met the primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo over weeks 8 and 12 (p=0.0009) -
- Separately announced 24-week data support the robust and durable activity of obexelimab and further validate its unique inhibitory mechanism of action -
- Obexelimab was well tolerated, and no new safety signals were observed -
WALTHAM, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.... (continue reading...)
8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be... (continue reading...)More Globe Newswire
View Older Stories-
Vitalist and MicroEJ Partner with BENIO to Launch First VitalOS™ Powered Smartwatch in Asia
-
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Maxim Power Corp. enters into a Gas Turbine and Generator Reservation Agreement and provides Prairie Lights Power Project Update
-
Itafos Files Technical Report for Updated Preliminary Economic Assessment for the Arraias Phosphate Project
-
Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update
-
ValOre Approves Phase 2 of Metallurgical Testwork for Pedra Branca PGE project in Brazil: Program Underway in Partnership with the University of Cape Town Department of Chemical Engineering
-
Freehand Debuts as New Company with Dedicated AI Teams for Supply Chain Spend Management
-
Emerita Intersects 9.2m Grading 1.4% Copper, 0.4% Lead, 1.3% Zinc, 0.41 g/t Gold and 21.48 g/t Silver at El Cura
-
Westhaven Lists on the OTCQB Venture Market
-
Media Advisory: Wear Red Canada highlights heart disease crisis facing Canadian women
-
Volatus Secures Drone Training Contract with NATO Defence Partner
-
Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the
-
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
-
Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment
-
Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy
-
Astera Labs Expands Global Footprint with New Israel Design Center to Support Growing Demand for AI Connectivity Solutions
-
Talisker Intersects 52.2 g/t Au over 0.55 metres, within 19.15 g/t over 1.60 metres, from the 2025 Bralorne Gold Project Resource Conversion Program
-
Osisko Development Awards Project and Construction Management Services Contract for the Development of the Cariboo Gold Project
-
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
-
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
-
First Intervention Shown to Lower Alzheimer’s and Dementia Incidence
-
GXO Announces Formation of Defense Advisory Board
-
Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the
-
Hain Celestial Reports Fiscal Second Quarter 2026 Financial Results
-
Sportradar to Power NBA Fan Experiences Across NBC Sports Regional Sports Networks through Advanced Data and Enhanced Visual Storytelling
-
Swvl Secures a New Up to $1.5 Million Multi-Year Contract in Saudi Arabia, Expanding Its Healthcare Mobility Footprint Across the GCC
-
STUDY BY RAMSEY SOLUTIONS FINDS AMERICANS PREFER FINANCIAL STABILITY OVER EXCITEMENT IN A PARTNER
-
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
-
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
-
Schouw & Co. share buy-back programme, week 6 2026
-
Prospect Enhanced Yield Fund, a Debt-Focused Structured Credit Interval Fund, Announces 10.6% Net Annualized 3-Month Total Return and 9.0% Cash Dividend Yield (on Net Asset Value) on Fully Deployed An
-
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Descartes Showcases AI Innovations to Help Improve Supply Chain and Logistics Operations
-
Microchip Technology Announces Proposed Private Offering of $600 Million of Convertible Senior Notes
-
Mandatory Notification of Trade
-
Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026
-
Man Group PLC : Form 8.3 - Beazley Plc
-
Azimut Confirms Significant Gold Discovery at Rosa, Wabamisk Property, James Bay, Québec
-
Apollo Reports Fourth Quarter and Full Year 2025 Results
-
dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)
-
Auction result of Treasury Bills - RIKV 26 0819
-
Comstock Metals Awarded Tax Abatement From the Nevada Governor’s Office of Economic Development
-
Reitar Logtech Signs Strategic Cooperation Framework Agreement with Optimize Integration Group, First-year Procurement Target of RMB 1 Billion
-
MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
-
Brunswick Corporation Named to Newsweek’s America’s Greatest Workplaces for Women 2026
-
B2BROKER Introduces Multi-Server and Cross-Platform Copy Trading, PAMM and MAM for Large Brokerages
-
Pokémon Unveils Massive, Yearlong ‘What’s Your Favorite?’ Campaign Commemorating 30 Years of the Iconic Franchise
-
DMC Global Schedules Fourth Quarter Earnings Release and Conference Call
